Literature DB >> 2446780

The regulatory effect of adherent cells on lymphokine activated killer cells.

Y Ibayashi1, D S Hoon, S H Golub.   

Abstract

We analyzed the effect of adherent cells on the induction of lymphokine-activated killer (LAK) cell activity by depleting adherent cells from peripheral blood lymphocytes (PBL) or by adding adherent cells to PBL before culture with interleukin-2. We found that adherent cells clearly down-regulate LAK cell induction. These inhibitory effects are dependent on the number of adherent cells added. Inhibitory effects of adherent cells are abolished by the addition of indomethacin to the LAK culture. Soluble factors derived from adherent cells, such as interferons and interleukin-1, have a slight enhancing effect on LAK induction. In contrast, adherent cells appear to inhibit LAK induction primarily by producing prostaglandin E2(PGE2). PGE2 in turn inhibits the induction of LAK effector cells by inhibiting the expression of the transferrin receptor on LAK cells. These effects are manifested most strikingly in the early phases of LAK induction.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2446780     DOI: 10.1016/0008-8749(87)90129-8

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  13 in total

1.  Human lymphokine-activated killer (LAK) cells. I. Depletion of monocytes from peripheral blood mononuclear cells by L-phenylalanine methyl ester: an optimization of LAK cell generation at high cell density.

Authors:  K H Leung
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Indirect inhibition of generation of murine lymphokine-activated killer cell activity in splenocyte cultures by interferon-gamma.

Authors:  T Y Chao; H Ohnishi; T M Chu
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

3.  Evidence that interleukin-4 suppression of lymphokine-activated killer cell induction is mediated through monocytes.

Authors:  B Brooks; H Parry; J Lawry; R Rees
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

4.  Indomethacin up-regulates the generation of lymphokine-activated killer-cell activity and antibody-dependent cellular cytotoxicity mediated by interleukin-2.

Authors:  A Eisenthal
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

5.  A Viscum album oligosaccharide activating human natural cytotoxicity is an interferon gamma inducer.

Authors:  E A Mueller; F A Anderer
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

6.  The inhibitory effect of human interferon alpha on the generation of lymphokine-activated killer activity.

Authors:  Y Tokuda; N Ebina; S H Golub
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  The CySF-L2 factor from dialysable human leucocyte extract activates natural killer cytotoxicity by induction of interferon gamma.

Authors:  I Doelker; F A Anderer
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

8.  Effects of lipopolysaccharide on interleukin-2-induced cytotoxic activity of murine splenocyte cultures: role of prostaglandin E2 and interferons.

Authors:  D Vaillier; R Daculsi; N Gualde
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

9.  High dose interleukin-12 exacerbates Bordetella pertussis infection and is associated with suppression of cell-mediated immunity in a murine aerosol challenge model.

Authors:  C R D Carter; B M Dagg; K M Whitmore; J R Keeble; C Asokanathan; D Xing; K B Walker
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

10.  Studies on cytotoxicity generated in human mixed lymphocyte culture. IV. Interleukin 2 alone or from mixed lymphocyte culture yields natural killer-like cytotoxic cells distinct from allospecific cytotoxic T lymphocytes.

Authors:  H Shau; J D Gray; S H Golub
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.